SYRE vs VRTX: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc. and Vertex Pharmaceuticals Inc in 2026
SYRE
Spyre Therapeutics Inc.
—
VRTX
Vertex Pharmaceuticals Inc
$529.59
Key Metrics Comparison
| Metric | SYRE | VRTX | Winner |
|---|---|---|---|
| Market Cap | $7.60B | $106.87B | VRTX |
| P/E Ratio | N/A | 29.67 | VRTX |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SYRE
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or VRTX a better investment?
Comparing SYRE and VRTX: Spyre Therapeutics Inc. has a market cap of $7.60B while Vertex Pharmaceuticals Inc has $106.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and VRTX?
SYRE (Spyre Therapeutics Inc.) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or VRTX?
Both SYRE and VRTX show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SYRE or VRTX?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SYRE or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $106.87B compared to $7.60B for SYRE.
Should I buy SYRE or VRTX in 2026?
Both SYRE and VRTX have investment merit. SYRE trades at $N/A while VRTX trades at $529.59. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and VRTX stock?
Key differences: Market Cap ($7.60B vs $106.87B), P/E Ratio (N/A vs 29.7x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SYRE or VRTX in 2026?
The choice between SYRE and VRTX depends on your investment goals. VRTX shows higher revenue growth (0.0%). VRTX has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SYRE and VRTX?
SYRE (Spyre Therapeutics Inc.) has a market cap of $7.60B, while VRTX (Vertex Pharmaceuticals Inc) has a market cap of $106.87B. VRTX is the larger company by market value.